One of the probable targets on 10q is the tumor suppressor gene PTEN, as suggested by previous studies demonstrating that PTEN mutation was predictive of a poor outcome and shorter survival in anaplastic oligodendrogliomas [26], [27]. The gene discussed is PTEN; the disease is anaplastic oligodendroglioma.